Ross Pelton on Rapamycin Longevity Series | How it all began
Master One Thing - Rapamycin Longevity Series
Unveiling the Power of Rapamycin
This chapter explores groundbreaking findings from the first human clinical trial on rapamycin, particularly its dosage effects on immune function in the elderly. The discussion also includes misconceptions in the medical community, ongoing research on aging, and personal experiences that underscore the potential health benefits of rapamycin. The speaker emphasizes the importance of education for both the public and healthcare professionals in promoting awareness about rapamycin for longevity and overall health.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
